© Khunaspix Dreamstime.
LCP Consulting senior director Julian Mosquera blogs on why pharmaceutical supply chains have to change: the short answer is that with a set of blockbusters coming off patent in the next five years, the era of high margins on drugs is coming to an end and producers now recognise that maintaining profits means a new focus on costs.
